The Evolution of Pituitary Surgery in an Australian Health Care Framework

Abstract

Background The outcomes in pituitary surgery have dramatically changed over the past 130 years. Endoscopic endonasal transsphenoidal approaches are now an accepted method for operating on pituitary tumors, a skillset which takes time to develop. The Australian health care framework provides a unique mixture of public and private care for a geographically dispersed population. In this article, we aim to examine how outcomes for patients in South Australia changed as endoscopic pituitary surgery was adopted and how the Australian health care framework influenced the development of a skull base team.

Methods The case notes of all patients undergoing pituitary surgery between 2006 and 2020 in South Australia. All patients treated by this author group were included.

Results A total of 428 pituitary adenomas were surgically treated. Overall, 182 out of 249 patients (70%) had a complete resection with no recurrence at follow-up, and 49 patients (19%) had a residual that was observed and did not require treatment. Therefore, 89% of patients between the years 2006 and 2020 did not require any further treatment following their pituitary surgery. Upon examination of the 142 patients with functional adenomas, 112 (79%) patients had no recurrence in hormonal dysfunction following surgery, and the remaining 30 (21%) patients required further treatment.

Conclusion We have demonstrated that acceptable outcomes can be achieved in a low-to-moderate volume setting across multiple hospitals when a coordinated effort is made to consolidate these cases within a small group of subspeciality-trained surgeons, as opposed to a more generalist approach.

Keywords

pituitary - skull base - endoscopy - health care

Publikationsverlauf

Eingereicht: 16. Januar 2024

Angenommen: 22. März 2024

Artikel online veröffentlicht:
15. April 2024

• References

• 1 Horsley V. On the technique of operations on the central nervous system. BMJ 1906; 2: 411-423
• 2 Artico M, Pastore FS, Fraioli B, Giuffrè R. The contribution of Davide Giordano (1864-1954) to pituitary surgery: the transglabellar-nasal approach. Neurosurgery 1998; 42 (04) 909-911 , discussion 911–912 [discussion]
• 3 Cavallo LM, Somma T, Solari D. et al. Endoscopic endonasal transsphenoidal surgery: history and evolution. World Neurosurg 2019; 127: 686-694
• 4 Liu JK, Das K, Weiss MH, Laws Jr ER, Couldwell WT. The history and evolution of transsphenoidal surgery. J Neurosurg 2001; 95 (06) 1083-1096
• 5 Cohen-Gadol AA, Laws ER, Spencer DD, De Salles AA. The evolution of Harvey Cushing's surgical approach to pituitary tumors from transsphenoidal to transfrontal. J Neurosurg 2005; 103 (02) 372-377
• 6 Hardy J. Transsphenoidal hypophysectomy. J Neurosurg 1971; 34 (04) 582-594
• 7 Hardy J. Transphenoidal microsurgery of the normal and pathological pituitary. Clin Neurosurg 1969; 16: 185-217
• 8 Jankowski R, Auque J, Simon C, Marchal JC, Hepner H, Wayoff M. Endoscopic pituitary tumor surgery. Laryngoscope 1992; 102 (02) 198-202
• 9 Jho HD, Carrau RL. Endoscopic endonasal transsphenoidal surgery: experience with 50 patients. J Neurosurg 1997; 87 (01) 44-51
• 10 Oldfield EH, Vortmeyer AO. Development of a histological pseudocapsule and its use as a surgical capsule in the excision of pituitary tumors. J Neurosurg 2006; 104 (01) 7-19
• 11 Hadad G, Bassagasteguy L, Carrau RL. et al. A novel reconstructive technique after endoscopic expanded endonasal approaches: vascular pedicle nasoseptal flap. Laryngoscope 2006; 116 (10) 1882-1886
• 12 Kassam AB, Prevedello DM, Carrau RL. et al. Endoscopic endonasal skull base surgery: analysis of complications in the authors' initial 800 patients. J Neurosurg 2011; 114 (06) 1544-1568
• 13 Servadei F, Rossini Z, Nicolosi F, Morselli C, Park KB. The role of neurosurgery in countries with limited facilities: facts and challenges. World Neurosurg 2018; 112: 315-321
• 14 Wormald PJ, McDonogh M. ‘Bath-plug’ technique for the endoscopic management of cerebrospinal fluid leaks. J Laryngol Otol 1997; 111 (11) 1042-1046
• 15 Gong X, Zhuo Y, Yuan H. et al. Outcome of endoscopic transsphenoidal surgery for recurrent or residual pituitary adenomas and comparison to non-recurrent or residual cohort by propensity score analysis. Front Endocrinol (Lausanne) 2022; 13: 837025
• 16 Broersen LHA, van Haalen FM, Biermasz NR. et al. Microscopic versus endoscopic transsphenoidal surgery in the Leiden cohort treated for Cushing's disease: surgical outcome, mortality, and complications. Orphanet J Rare Dis 2019; 14 (01) 64
• 17 Du AT, Pang JC, Victor R. et al. The influence of facility volume and type on skull base chordoma treatment and outcomes. World Neurosurg 2022; 166: e561-e567
• 18 Hussein Z, Grieve J, Dorward N. et al. Non-functioning pituitary macroadenoma following surgery: long-term outcomes and development of an optimal follow-up strategy. Front Surg 2023; 10: 1129387
• 19 Gerges MM, Rumalla K, Godil SS. et al. Long-term outcomes after endoscopic endonasal surgery for nonfunctioning pituitary macroadenomas. J Neurosurg 2020; 134 (02) 535-546
• 20 Charleux T, Vendrely V, Huchet A. et al. Management after initial surgery of nonfunctioning pituitary adenoma: surveillance, radiotherapy or surgery?. Radiat Oncol 2022; 17 (01) 165
• 21 Zerris VA, James KS, Roberts JB, Bell E, Heilman CB. Repair of the dura mater with processed collagen devices. J Biomed Mater Res B Appl Biomater 2007; 83 (02) 580-588
• 22 Hardesty DA, Montaser A, Kreatsoulas D. et al. Complications after 1002 endoscopic endonasal approach procedures at a single center: lessons learned, 2010-2018. J Neurosurg 2021; 136 (02) 393-404